文献速递呼吸危重症与机械通气

急诊科肺保护性通气与有创机械通气患者结局及费用的关联

Lung-Protective Ventilation and Associated Outcomes and Costs Among Patients Receiving Invasive Mechanical Ventilation in the ED.
PubMed 文献 · Chest · 2020-09-20

该回顾性注册研究分析2011-2017年8个急诊科4174例有创机械通气成人患者,58.4%在急诊科接受潮气量≤8 mL/kg预测体重的肺保护性通气。肺保护性通气与住院死亡风险降低(aOR 0.91)、ARDS发生风险降低(aOR 0.87)、机械通气时间缩短、住院时间缩短及总费用降低相关。

要点

  • 急诊科肺保护性通气与住院死亡风险降低相关(aOR 0.91,95%CI 0.84-0.96)。
  • 急诊科肺保护性通气与ARDS发生风险降低相关(aOR 0.87,95%CI 0.81-0.92)。
  • 急诊科肺保护性通气与机械通气时间、住院时间缩短及总费用降低相关。

核心结论

  • 急诊科使用肺保护性通气与住院死亡率降低、ARDS发生率降低、住院时间缩短及总费用降低相关。
  • 制定促进急诊科常规使用肺保护性通气的方案可能具有价值。

研究设计与样本

  • 回顾性分析2011-2017年前瞻性注册研究,纳入8个急诊科连续收治的≥18岁有创机械通气成人患者。
  • 肺保护性通气定义为潮气量≤8 mL/kg预测体重。
  • 主要结局为住院死亡率,次要结局包括ARDS发生、住院时间及总住院费用。

主要发现

  • 共纳入4174例患者,其中2437例(58.4%)在急诊科接受肺保护性通气。
  • 肺保护性通气与住院死亡风险降低相关(aOR 0.91,95%CI 0.84-0.96)。
  • 肺保护性通气与ARDS发生风险降低相关(aOR 0.87,95%CI 0.81-0.92)。

关键数值与推荐

  • 肺保护性通气定义:潮气量≤8 mL/kg预测体重。

临床怎么用

  • 急诊科对有创机械通气患者可考虑常规采用潮气量≤8 mL/kg预测体重的肺保护性通气策略。
  • 急诊科启动机械通气时即应关注潮气量设置,并考虑制定促进肺保护性通气常规使用的方案。

局限性

  • 本研究为回顾性分析,虽基于前瞻性注册研究,仍可能存在残余混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Invasive mechanical ventilation is often initiated in the ED, and mechanically ventilated patients may be kept in the ED for hours before ICU transfer. Although lung-protective ventilation is beneficial, particularly in ARDS, it remains uncertain how often lung-protective tidal volumes are used in the ED, and whether lung-protective ventilation in this setting impacts patient outcomes. RESEARCH QUESTION: What is the association between the use of lung-protective ventilation in the ED and outcomes among invasively ventilated patients? STUDY DESIGN AND METHODS: A retrospective analysis (2011-2017) of a prospective registry from eight EDs enrolling consecutive adult patients (≥ 18 years) who received invasive mechanical ventilation in the ED was performed. Lung-protective ventilation was defined by use of tidal volumes ≤ 8 mL/kg predicted body weight. The primary outcome was hospital mortality. Secondary outcomes included development of ARDS, hospital length of stay, and total hospital costs. RESULTS: The study included 4,174 patients, of whom 2,437 (58.4%) received lung-protective ventilation in the ED. Use of lung-protective ventilation was associated with decreased odds of hospital death (adjusted OR [aOR], 0.91; 95% CI, 0.84-0.96) and development of ARDS (aOR, 0.87; 95% CI, 0.81-0.92). Patients who received lung-protective ventilation in the ED had shorter median duration of mechanical ventilation (4 vs 5 days; P < 0.01), shorter median hospital length of stay (11 vs 14 days; P < .001), and reduced total hospital costs (Can$44,348 vs Can$52,484 [US$34,153 vs US$40,418]; P = .03) compared with patients who received higher tidal volumes. INTERPRETATION: Use of lung-protective ventilation in the ED was associated with important patient- and system-centered outcomes, including lower hospital mortality, decreased incidence of ARDS, lower hospital length of stay, and decreased total costs. Protocol development promoting the regular use of lung-protective ventilation in the ED may be of value.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Fernando SM, Fan E, Rochwerg B, et al. Lung-Protective Ventilation and Associated Outcomes and Costs Among Patients Receiving Invasive Mechanical Ventilation in the ED. Chest. 2020. PMID: 32966812. doi:10.1016/j.chest.2020.09.100

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。